| Intrinsic Valuation of: DRREDDY | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 50 | Market Cap | ₹1,113B | |||||
| 2021 | - | - (-) | P/E Ratio | 27 | Total Asset | ₹493B | |||||
| 2022 | ₹9B | - (-) | Net Income | ₹57B | Total Debt | ₹4B | |||||
| 2023 | ₹40B | 341.6% (285.1%) | EBITDA | ₹97B | Total Liab | ₹156B | |||||
| 2024 | ₹18B | -55.0% (-60.4%) | Opr Margin | 22.12 | Debt/Equity | 0.01 | |||||
| 2025 | ₹12B | -33.2% (-42.7%) | PreTax Margin | 21.25 | BV/Share | 270 | |||||
| 5Y Average FCF | ₹20B | 15.0% (60.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.01% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | ₹17B | MBG Intrinsic Value | ₹450 | ||||||||
| 2027 | ₹19B | ||||||||||
| 2028 | ₹20B | ||||||||||
| 2029 | ₹22B | ||||||||||
| 2030 | ₹23B | ||||||||||
| 2031 | ₹24B | ||||||||||
| Terminal Value | ₹534B | Net Worth/Share | ₹405 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹453B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹15B | ₹557 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹4B | WACC | 6.5% | 525 | 570 | 627 | 701 | 798 | |||
| Equity Value | ₹464B | 7.1% | 466 | 501 | 543 | 595 | 661 | ||||
| Shares Outstanding | 832,594,805 | 7.8% | 420 | 447 | 480 | 518 | 566 | ||||
| 8.4% | 382 | 404 | 429 | 459 | 494 | ||||||
| DCF Intrinsic Value | ₹557 | 9.0% | 350 | 368 | 388 | 411 | 439 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||